Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML
PHASE2
This phase II trial tests how well venetoclax with cladribine and cytarabin...
Status
Recruiting
Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
PHASE3
This randomized phase III trial studies combination chemotherapy with blina...
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
PHASE2
This phase II trial studies how well inotuzumab ozogamicin works in treatin...
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
PHASE3
This phase III trial compares higher dose chemotherapy, with vincristine, d...